The effects of maintenance schedules following pulmonary rehabilitation in patients with chronic obstructive pulmonary disease:a randomised controlled trial by Wilson, Andrew M et al.
The effects of maintenance schedules
following pulmonary rehabilitation
in patients with chronic obstructive
pulmonary disease: a randomised
controlled trial
Andrew M Wilson,1,2 Paula Browne,2 Sandra Olive,2 Allan Clark,1 Penny Galey,2
Emma Dix,2 Helene Woodhouse,2 Sue Robinson,2 Edward C F Wilson,3
Lindi Staunton4
To cite: Wilson AM,
Browne P, Olive S, et al.
The effects of maintenance
schedules following
pulmonary rehabilitation
in patients with chronic
obstructive pulmonary
disease: a randomised
controlled trial. BMJ Open
2015;5:e005921.
doi:10.1136/bmjopen-2014-
005921
▸ Prepublication history for
this paper is available online.
To view these files please
visit the journal online
(http://dx.doi.org/10.1136/
bmjopen-2014-005921).
Received 16 June 2014
Revised 28 October 2014
Accepted 30 October 2014
For numbered affiliations see
end of article.
Correspondence to
Dr Andrew M Wilson;
a.m.wilson@uea.ac.uk
ABSTRACT
Objectives: Pulmonary rehabilitation (PR) provides
benefit for patients with chronic obstructive pulmonary
disease (COPD) in terms of quality of life (QoL) and
exercise capacity; however, the effects diminish over
time. Our aim was to evaluate a maintenance programme
for patients who had completed PR.
Setting: Primary and secondary care PR programmes in
Norfolk.
Participants: 148 patients with COPD who had
completed at least 60% of a standard PR programme
were randomised and data are available for 110 patients.
Patients had greater than 20 pack year smoking history
and less than 80% predicted forced expiratory volume in
1 s but no other significant disease or recent respiratory
tract infection.
Interventions: Patients were randomised to receive a
maintenance programme or standard care. The
maintenance programme consisted of 2 h (1 h
individually tailored exercise training and 1 h education
programme) every 3 months for 1 year.
Primary and secondary outcome measures: The
Chronic Respiratory Questionnaire (CRQ) (primary
outcome), endurance shuttle walk test (ESWT), EuroQol
(EQ5D), hospital anxiety and depression score (HADS),
body mass index (BMI), body fat, activity levels (overall
score and activity diary) and exacerbations were assessed
before and after 12 months.
Results: There was no statistically significant difference
between the groups for the change in CRQ dyspnoea
score (primary end point) at 12 months which amounted
to 0.19 (−0.26 to 0.64) units or other domains of the
CRQ. There was no difference in the ESWT duration
(−10.06 (−191.16 to 171.03) seconds), BMI, body fat,
EQ5D, MET-minutes, activity rating, HADS, exacerbations
or admissions.
Conclusions: A maintenance programme of three
monthly 2 h sessions does not improve outcomes in
patients with COPD after 12 months. We do not
recommend that our maintenance programme is
adopted. Other methods of sustaining the benefits of PR
are required.
Trial registration number: NCT00925171.
INTRODUCTION
Chronic obstructive pulmonary disease
(COPD) is a major healthcare problem, with
considerable human and economic costs. It is
estimated that 3 million people in the UK have
COPD and costs the National Health Service
nearly £1 billion per year.1 COPD is a leading
cause of death worldwide,2 is relatively unre-
sponsive to treatment and is expected to have
greater prevalence, morbidity and mortality in
the future.3 However, pulmonary rehabilitation
(PR) is an available therapeutic option with
good evidence of beneﬁt for patients in terms
of quality of life and daily functioning4 and it
is recommended in national and international
guidelines.5 6
Although there is convincing evidence that
PR offers clinically relevant beneﬁt for patients
in the short to medium term (6 months to
1 year), all studies have shown that the initial
beneﬁts diminish over time.6 Guidelines
Strengths and limitations of this study
▪ This study addresses an important clinical issue:
the effects of pulmonary rehabilitation are short
lived.
▪ A well conducted randomised controlled study of
maintenance sessions following pulmonary
rehabilitation in patients with chronic obstructive
pulmonary disease.
▪ This study was adequately powered to detect a
clinically relevant difference in a respiratory-
related, health-related quality of life tool the
Chronic Respiratory Questionnaire.
▪ The intervention was not intensive enough, did
not start early enough and was not of sufficient
duration demonstrate a clinically relevant
change.
▪ Activity was assessed using questionnaires rather
than measured directly using accelerometers.
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highlight the importance of continued exercise following
PR; however, the utility of maintenance programmes is
unclear. Current American PR guidelines5 state “the role
of maintenance [PR] interventions…remains uncertain at
this time” and there no speciﬁc recommendations about
maintenance in the UK guidelines.6 Indeed there is a
great variation in the delivery of PR, with only a third of
UK centres offering any formal follow-on care or training
after the initial PR programme,7 highlighting the need for
more research in this area.
Previously, researchers have explored the utility of
maintenance sessions and a recent meta-analysis has
shown that intensive maintenance sessions have shown
medium-term beneﬁts in terms of exercise capacity.8
However, the majority of studies included in this analysis
required that patients attend PR sessions on a weekly
basis for a prolonged period of time. Indeed there is
confusion as to whether these are maintenance pro-
grammes or continuation of the initial PR programme.6
In view of the considerable resource implications of
intensive maintenance or continual programmes for all
dyspnoeic patients with COPD we aimed to evaluate the
long-term effect of a low-intensity (3 monthly) mainten-
ance programme in terms of health-related quality of
life (HRQoL) in patients who had completed an initial
PR programme. We also explored secondary end points
that are relevant to patients with COPD, including exer-
cise capacity, anxiety and depression, body mass index
and fat-free mass, activity levels and exacerbations.
METHODS
Design
This was a randomised, controlled, parallel, investigator-
blind study of a maintenance programme in patients with
COPD following a standard PR programme. Patients were
recruited from primary and secondary care PR pro-
grammes in Norfolk, UK between July 2009 and
November 2011. The study was conducted in accordance
with Good Clinical Practice and all participants gave
written informed consent.
Patients
Eligible patients were aged over 35 years, had a physician
labelled diagnosis of COPD, emphysema or chronic
bronchitis with a >20 pack-year smoking history and a
forced expiratory volume in 1 s (FEV1) of <80%.
Patients were excluded if they had signiﬁcant cardiac or
pulmonary disease other than COPD, a myocardial
infarction within the previous 6 months or unstable
angina, respiratory infection (deﬁned as cough, anti-
biotic use or purulent sputum within 4 weeks prior to
randomisation), severe or uncontrolled comorbid
disease, or abnormalities in cognitive functioning that
would limit the patient’s ability to undertake the inter-
vention. To enter the randomised part of the study,
patients had to have completed at least 60% of the ses-
sions in the initial PR programme.
All patients underwent the current PR programme
offered within Norfolk. This consists of eight weekly
supervised exercise training sessions. Each session con-
sisted of 1 h of strength and endurance training includ-
ing walking, cycling, standing from sitting, arm exercises
using dumbbells and step-ups. These are high-intensity
sessions with patients being expected to exercise at 85%
of their maximum capacity. Prior to, or following each
exercise training session, patients attended an educa-
tional session for 1 h. This was in the form of a seminar
and included the following topics: relaxation, physiology,
medication, emotions, nutrition, coping skills, social ser-
vices and maintenance techniques. In addition patients
were asked to undertake endurance exercises every day,
and strength exercises two more times a week at home
as this has been shown to be as beneﬁcial as twice
weekly supervised sessions.9
Eligible patients were randomised after baseline
post-PR measure on a 1:1 basis using a computer gener-
ated randomised sequence to either of the following.
Maintenance programme
This consisted of one session, of 2 h duration, conducted
every 3 months comprising 1 h of education and 1 h of
exercise training. The sessions were supervised, individu-
ally tailored and included strength and endurance train-
ing given the importance of these components.10–12 The
sessions took place in the same gynmasium as the initial
PR programme and for the majority of patients by the
same PR multidisciplinary team. The groups comprised
the same patients as in the initial PR programme to maxi-
mise peer support and improve adherence.13 The main-
tenance programme was a rolling programme for the
duration of the study and the number of participants in
the group varied between 4 and 10 individuals. Patients
received a reminder letter 2 weeks before the session and
a reminder phone call 1 week before the session. As with
the initial programme, patients received an individually
tailored exercise prescription, to be undertaken at home,
which was reviewed at each session and modiﬁed as
appropriate. This was in addition to the standard advice
to undertake strength and endurance exercises at home
and an invitation to attend the Norwich Breathe Easy
Group. There was no formal phone call or other review/
follow-up between the sessions.
The education sessions were entitled ‘Keeping Well’
(including topics such as smoking cessation, healthy
eating, the importance of exercise and techniques for
managing exacerbations), ‘Keeping Active’ (including
coping with breathlessness, revision of exercise strat-
egies, a brainstorm/group discussion on different strat-
egies and overcoming the barriers to activity) and
‘Keeping Going’ (including psychological issues of a
long-term condition, dealing with psychological pro-
blems, methods of being able to relax and how carers
can help). They were repeated in 9 monthly cycles so
that all patients underwent each education session once.
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The exercise training comprised supervised strength
and endurance training including walking, cycling, stand-
ing from sitting, arm exercises using dumbbells and
step-ups. The training was individually tailored to the
patients’ abilities and patients received a written report
on their progress with positive re-enforcement being pro-
vided by demonstrating the extent to which they had
improved during the initial programme if appropriate.
Patients were encouraged to review and reset their per-
sonal goals. The groups comprised of patients who
attended the initial PR session where possible and time
was permitted for social interaction and peer support.
Control
Patients received the standard advice to undertake
strength and endurance exercises at home and an invita-
tion to attend the Norwich Breathe Easy Group.
Randomisation was undertaken by an independent
researcher (CB), using the code generated by the statisti-
cian, who had no role other than this in the study and
had no knowledge of the patients’ details or character-
istics. This researcher mailed letters to the patients
informing them of their allocation group and inviting
those in the intervention group to attend the mainten-
ance PR sessions.
Measurements
Prior to enrolment in the PR programme, all patients
underwent standard baseline assessments. These
included demographic details, medical history, height
and weight, spirometry, an incremental shuttle walk test
(ISWT)14 to determine a predicted maximum oxygen
consumption (VO2 max), an endurance shuttle walk test
(ESWT)15 at 85% of VO2 max, the CRQ,
16 EuroQol
(EQ5D),17 hospital anxiety and depression score
(HADS),18 and skinfold thickness measured at four sites
(biceps, triceps, subscapular and suprailiac). At the end
of PR and, for those entering the clinical study,
12 months following randomisation, patients underwent
ESWT at the same rate as baseline, CRQ, EQ5D, HADS,
height and weight, skinfold thickness and an assessment
of activity in the preceding month.
At 3, 6 and 9 months following randomisation patients
completed the CRQ and a questionnaire to assess
activity in the preceding month. Activity levels were
recorded as an overall score on a visual analogue scale
(from 0 to 100) and also from intensity and duration of
activity recorded on a daily exercise diary. Details of exacer-
bations and hospitalisations were also captured from
patient questionnaires retrospectively every 3 months. All
of the questionnaires were collected by post. Vital status was
obtained from hospital records.
Baseline measurements were undertaken by the PR
team and outcome measurements were undertaken by a
research team (AMW, HW, SR) who were blind to the
intervention. We used a standard protocol for the ESWT
to reduce inter observer bias.
Statistical analysis
The primary outcome was the change from baseline in
the dyspnoea domain of the CRQ score at 12 months.
A sample size of 98 patients had 80% power to detect a
treatment difference, at a two-sided 5% signiﬁcance
level, of 0.5 units in the dyspnoea domain of the CRQ,
which is considered to be a clinically signiﬁcant differ-
ence.19 This was based on a two-sample t test and on the
assumption that the SD was 0.87 units obtained from
unpublished local pilot data. Secondary outcomes were
the change from baseline in other domains of the CRQ,
ESWT, body mass index (calculated as weight divided by
the square of the height), body fat (calculated from skin
fold thickness as previously described),20 HADS and
EQ5D questionnaire. Metabolic equivalents of energy
were calculated by multiplying the intensity of exercise
by the exercise duration from the daily exercise diary.
Analysis was on the intention-to-treat principle with any
drop-outs being replaced using imputation. This was
undertaken by Iteratively Chain Equations imputing
using the values of all observed baseline and post-
baseline outcome measures as well as treatment group.
A total of ﬁve imputed data sets were constructed and
the results were combined using Rubin’s equation. An a
priori PPl analysis was undertaken including those
patients who attended all of the maintenance sessions
and provided data for the ﬁnal outcome measures.
Continuous outcomes were assessed by the two-sample
t test. Exacerbation and hospitalisation rates were ana-
lysed using a negative binomial regression model.
RESULTS
Baseline characteristics
Two hundred and ﬁfty (139 men; 111 women) patients
provided informed consent to participate in the study.
They had a mean (SD) age of 69.2 (9.2) years, FEV1 41
(16) % predicted, baseline CRQ dyspnoea score of 2.49
(0.99) units and baseline ESWT distance of 192.5
(132.1) metres. The majority (237 (94.8%) patients)
started the standard PR programme (ﬁgure 1). There
was a large withdrawal rate prior to randomisation
mainly due to inability to complete the standard PR pro-
gramme (56 (23.6%) patients) and 148 patients entered
the randomised part of the study. These patients had a
mean (95% CI) improvement in CRQ following the pro-
gramme of 0.76 (0.59 to 0.93) units, which was statistic-
ally and clinically signiﬁcant. There remained a
signiﬁcant improvement in CRQ dyspnoea at the end of
maintenance period compared with the pre-PR session
for the group as a whole. The intervention and control
groups were well matched in terms of characteristics
measured before and after the initial PR programme
(table 1) although the control group walked further
than the intervention group before and after initial PR
in ESWT. Of the 73 patients randomised to the interven-
tion, 38 (23 men; 15 women) patients (52%) completed
all of the maintenance sessions. These patients had a
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baseline age: 70.1 (8.7) years, CRQ dyspnoea: 3.29 (1.1),
ESWT duration 490.1 (400.0) seconds and ESWT dis-
tance (434.1 (378.7) metres.
Outcome
No statistically signiﬁcant differences were detected
between the intervention and control groups for the
Figure 1 Disposition of patients. Although the majority (237 (94.8%) patients) started the standard pulmonary rehabilitation (PR)
programme, there was a large withdrawal rate prior to randomisation mainly due to inability to complete the standard PR
programme (56 (23.6%) patients). n=number of patients.
Table 1 Summary of baseline characteristics for all individuals
Control
Pre PR
Intervention
Pre PR
Control
Post PR
Intervention
Post PR
N Mean (SD) N Mean (SD) N Mean (SD) N Mean (SD)
Age (years) 75 69.3 (8.9) 73 67.3 (15.1) 75 73
Male n (%) 75 50.0 (66.7) 73 41.0 (56.2) 75 73
CRQ dyspnoea 74 2.5 (1.2) 72 2.6 (1.0) 74 3.3 (1.3) 72 3.2 (1.1)
CRQ fatigue 74 3.4 (1.1) 72 3.2 (1.1) 74 4.0 (1.1) 72 3.9 (1.2)
CRQ emotion 74 4.4 (1.3) 72 4.2 (1.3) 74 4.9 (1.1) 72 5.2 (4.5)
CRQ mastery 74 4.8 (1.2) 72 4.2 (1.4) 74 5.0 (1.5) 72 4.6 (1.6)
ESWT (s) 69 223.5 (94.4) 67 184.4 (84.1) 69 540.7 (411.9) 67 520.9 (400.5)
ESWT (m) 70 232.0 (150.0) 65 174.8 (98.7) 70 573.5 (451.6) 65 452.9 (372.2)
Body mass index (kg/m2) 59 28.2 (6.0) 53 28.8 (5.7) 59 28.6 (6.3) 53 28.7 (5.8)
Body fat (%) 69 30.6 (7.1) 62 31.8 (7.4) 69 30.5 (6.7) 62 31.7 (7.2)
HADS 61 12.4 (6.9) 57 13.5 (6.9) 61 11.5 (6.9) 57 11.9 (7.0)
EQ5D 70 0.7 (0.2) 67 0.6 (0.3) 70 0.7 (0.3) 67 0.6 (0.2)
Activity (MET-minutes) 60 541.8 (460.3) 49 550.1 (411.6) 60 611.1 (543.7) 49 611.7 (460.6)
Activity (VAS) 57 35.4 (22.5) 58 34.5 (16.3) 57 45.5 (20.6) 58 39.6 (21.5)
CRQ, Chronic Respiratory Questionnaire; EQ5D, EuroQol; ESWT, endurance shuttle walk test; HADS, hospital anxiety and depression score;
MET, metabolic equivalents; PR, pulmonary rehabilitation; VAS, visual analogue scale.
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CRQ dyspnoea score (0.19 (−0.26 to 0.64) units) or
other domains of the CRQ, the ESWT distance between
the two groups (109.1 (−100.1 to 318.2) metres), BMI,
body fat EQ5D, MET-minutes, activity rating, HADS,
exacerbations or admissions (table 2). There was a higher
level of self-reported activity according to the visual ana-
logue score but not the reported metabolic equivalent
(MET)-minutes per week (although these ﬁndings were
based on a small number of patients responding appro-
priately). There were no study related adverse events.
Three patients died in the intervention group and four
patients died in the standard care group (ﬁgure 1). The
results of the per protocol (PP) analysis were in keeping
with the intention to treat analysis except that there was a
signiﬁcantly greater MET-minutes per week in the inter-
vention group, but more exacerbations and admissions.
However, these data (for activity especially) are based on
small numbers of patients and caution should be exer-
cised when interpreting them. In addition, the PP
control group consists of individuals who would have
complied with the intervention as well as individuals who
would not have complied, whereas the intervention
group in the PP only contains individuals who have com-
plied. This means that, unlike the situation with a
pharmaceutical intervention, the difference between the
two groups differ by their compliance behaviour as well
as the intervention. However, they do suggest that there
may be some harm associated with the intervention.
There was no difference with any measurement for the
analyses which include imputed data.
There was no difference in any of the CRQ measures
at any of the 3-monthly measurements between the
intervention and control groups (ﬁgure 2). Both groups
had a signiﬁcant deterioration in CRQ dyspnoea score
3 months following PR (control −0.45 (−0.68 to −0.23)
units, intervention −0.38 (−0.70 to −0.06) units).
DISCUSSION
No signiﬁcant between-group differences were found for
changes at 12 months in HRQoL assessed by CRQ or
EQ5D, exercise capacity assessed by ESWT, anxiety and/
or depression, BMI or body fat (captured to ensure any
potential change in BMI was not due to change in skel-
etal muscle bulk), although the magnitude of improve-
ment in the ESWT distance (109 m) may have been
clinically signiﬁcant (difference of 70–82 m21). Our ﬁnd-
ings were not due to inadequacy of the initial PR pro-
gramme as there was a statistically and clinically relevant
improvement in the dyspnoea domain of the CRQ
(primary outcome) with the initial PR and an overall
sustained improvement compared to baseline in both
groups. Although patients reported to be exercising
more this did not translate into increased activity.
However, the assessment of activity was captured using
an unvalidated questionnaire and the post-PR values are
likely to represent peak values given that this measure-
ment reﬂects the period when patients were undergoing
the initial PR programme. Our results suggest that main-
tenance programmes, delivered in the manner in this
study, should not be used in order to achieve improve-
ments in these outcomes.
Foglio et al22 evaluated the effect of repeating a PR
course after 1 year compared to standard care and
reported no signiﬁcant difference in any of the outcome
measures at 2 years except a lower frequency of exacerba-
tions. In the intervention group, pre-PR values were back
to baseline suggesting that a 12-month gap following
initial PR is too long. This would be in keeping with data
suggesting that by 6 months, patients are starting to lose
the beneﬁts of PR. By repeating the PR programme at
6 months, Romagnoli et al23 showed a reduction in the
number of prolonged hospitalisations at 1 year, with
improvements in symptoms and HRQoL, in a study of 35
patients. Ries et al24 randomised patients to attend a
monthly maintenance schedule or standard care and
demonstrated signiﬁcant differences in exercise toler-
ance and health status at 1 year.
However, Brooks et al25 did not show any difference
between patients undergoing a conventional mainten-
ance PR (3-monthly follow-up) or enhanced mainten-
ance PR (fortnightly phone calls and monthly supervised
visits) after 1 year. The lack of effect may be due to the
beneﬁcial effect of the 3-monthly reviews as the rate of
home exercise was the same in the two groups. Our study
is in keeping with that of Brooks et al25 as we did not ﬁnd
any improvement in outcomes with 3-monthly revision
supervised PR sessions. Despite our efforts to motivate
the patients at these sessions we did not identify any sig-
niﬁcant increased daily activity. It is likely that the lack of
sustained activity is related to the lack of improvement in
exercise capacity and patient reported outcomes.
It is likely that our maintenance programme was not
sufﬁciently frequent to sustain a beneﬁt following initial
PR. Several studies have evaluated the effect of mainten-
ance PR programmes requiring frequent sessions. Indeed
a recently published systematic review and meta-analysis
reported improvement in medium-term outcomes with
maintenance PR programmes, with signiﬁcant improve-
ments in exercise capacity, but not disease speciﬁc
HRQOL as assessed by CRQ or St Georges Respiratory
Questionnaire.8 All of the studies analysed within that
meta-analysis, except the studies of Brooks et al25 and Ries
et al24 (discussed above), evaluated maintenance pro-
grammes comprising supervised sessions of at least once
per week. Given the costs associated with intensive ses-
sions that are supervised by healthcare professionals, and
the lack of effect of less intensive interventions, other
methods of sustaining activity are required.
Several researchers have investigated less staff intensive
methods of improving activity and quality of life in patients
with COPD. In a small study of 21 patients, alternate day
phone calls for 2 weeks increased activity, measured using
accelerometers, exercise capacity and quality of life.26
However, this intervention involved frequent phone calls
and the sustained effects are not known. Although a pilot
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study of an internet–based self-management programme
for dyspnoea improved symptoms in patients with
COPD,27 a larger study did not show improvements in dys-
pnoea compared with controls receiving general health
education.28 However, this intervention was well received
and did improve exercise behaviour and self-efﬁcacy. In
another study, patients with COPD were able to review
their activity and receive educational and motivational
material on a web-page, by wearing a pedometer which
was linked to the internet.29 The patients increased their
activity, were more informed about their potential level of
achievement and stated they would recommend the pro-
gramme to others. Other researchers have incorporated
exercise training with a home exercise programme and
goal setting within a patient directed self-management
manual for COPD. The Self-Management Programme of
Activity, Coping and Education for Chronic Obstructive
Pulmonary Disease (SPACE for COPD) programme, has
been shown to improve exercise capacity and breathless in
a pilot study30 and a larger study (presented at the
European Respiratory Society Congress 2012) showed
improvements in CRQ, ESWT distance and anxiety.
There was a considerable rate of drop-out in terms of
patients withdrawing from the initial programme and
also the maintenance programme. This is despite our
encouragement for patients to continue to exercise and
also a referral to the local patient support group
(Breathe Easy Norwich) which is associated with the
British Lung Foundation. In a qualitative review of focus
groups comprising patients attending a maintenance pro-
gramme, patients expressed more overall beneﬁts than
barriers to attending the programme. Attendance was
improved by a feeling of improved quality of life but
exacerbations, fatigue, transport and poor weather were
barriers.31
This was a large adequately powered study with broad
inclusion criteria and therefore we are conﬁdent that the
results are robust and generalisable; however, there may
have been some differences between the two groups at
baseline. Although we ensured that the study investigator
was blind, the patients could not be blind to the treat-
ment allocation and did not have a sham intervention. By
collecting activity questionnaires at 3-month intervals in
both groups, we may have increased the activity in the
control group; however, this does not seem likely from
our data. Assessing activity levels using accelerometer or
patient independent device would have provided more
accurate data than that obtained from questionnaires.
There was a relatively poor concordance rate with only
half of patients attending all of the 3-monthly mainten-
ance sessions. However, our results were similar when
analysing the subgroup of patients complying with the
intervention in the PP analysis suggesting that improved
patient attendance would not have changed the ﬁndings
of the study. Our initial PR comprised weekly visits rather
than twice weekly visits as is usual in the UK;6 however,
there are no data suggesting that twice weekly PR is super-
ior to once weekly PR sessions. Indeed O’Neill et al9 have
shown that these interventions result in similar long-term
outcomes. Furthermore, our short-term beneﬁts of PR
were clinically signiﬁcant and there remained a signiﬁ-
cant improvement in CRQ dyspnoea at the end of main-
tenance period compared with the pre-PR session for the
group as a whole. It is unlikely that a twice weekly or
Figure 2 Change in components of the Chronic Respiratory Questionnaire (CRQ) at 3−month intervals. There was no
difference in any of the CRQ measures at any of three monthly measurements between the intervention and control groups.
The control is the solid line and the intervention is dashed line. The bars represent the 95% CIs. PR, pulmonary rehabilitation.
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longer initial PR programme will alter the conclusions of
this study. We corrected for baseline values in order to
account for any differences including the ESWT.
In conclusion, a maintenance programme of a 2 h
session every 3 months does not improve outcomes in
patients with COPD after 12 months. Despite our efforts
to motivate the patients at these sessions we did not
identify any signiﬁcant increased daily activity. In add-
ition, much of the beneﬁcial effects of the initial PR
were lost before the ﬁrst maintenance session at
3 months. We do not recommend that our maintenance
programme is adopted and suggest that other methods
of sustaining the beneﬁts of PR are required.
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